A healthy BMI appears to be particularly critical for increasing the number of years spent without chronic conditions like CHD.

Dire forecasts for Europe, convalescent plasma as treatment, protecting OR staff, hydroxychloroquine shortages, and more.

The results were unexpected given prior animal research showing as much as a 50% improvement in survival.

RCTs are paused or slowing to a trickle. Researchers predict data gaps, less funding, and new priorities when the pandemic ends.

Nine injuries have been reported due to catheter tips detaching during procedures or prep.

In the 3 months after an aortic or mitral surgery, the DOAC was protective against thromboembolism and major bleeding.

Procedural characteristics and safety compare favorably with what was seen in PROTECT AF and PREVAIL, a researcher says.

The study findings match those seen with evolocumab, the other available PCKS9 inhibitor, in the TAUSSIG trial.

The metric assesses “alive and well” at 30 days and will be used to compare hospitals performance against the national average.

Hydroxychloroquine, chloroquine, and azithromycin all prolong QT interval. The next step is studying if their benefit exceeds risk.